Lactate-buffered and bicarbonate-buffered solutions with less glucose degradation products in a two-chamber system

Peritoneal Dialysis International

Volumn 20, Issue SUPPL. 2, 2000, Pages

  Passlick Deetjen, Jutta ^a   Lage, Cristina ^a  

^a FRESENIUS MEDICAL CARE   (Germany)

Author keywords

Biocompatibility; Glucose degradation products; PH neutral solution; Two chamber bag

Indexed keywords

BICARBONATE; GLUCOSE; GLUCOSE DERIVATIVE; LACTIC ACID; PERITONEAL DIALYSIS FLUID;

ACIDITY; ARTICLE; BIOCOMPATIBILITY; BIOPSY; CELL FUNCTION; CELL PH; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DEVICE; DRUG DEGRADATION; GLYCATION; HOST RESISTANCE; HUMAN; HUMAN TISSUE; HYPEROSMOLARITY; INDUSTRY; KIDNEY TRANSPLANTATION; MEMBRANE DAMAGE; MEMBRANE PERMEABILITY; MESOTHELIUM CELL; NEUTROPHIL; PAIN; PERITONEUM; PERITONITIS; PRIORITY JOURNAL; TECHNIQUE; ULTRAFILTRATION;

EID: 0034044155     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080002002s09     Document Type: Article

References (36)

1. Pastan S, Bailey J. Dialysis therapy. N Engl J Med 1998; 338(20):1428-36.
2. Jörres A. Bio-(in)-kompatibilität der peritonealdialyse. Dialyse-Journal 1996; 55:103-8.
3. Bunchman TE, Ballal SH. Treatment of inflow pain by pH adjustment of dialysate in peritoneal dialysis. Perit Dial Int 1991; 11:179-80.
4. Yamamoto T, Sakura T, Yamakawa M, Horiuchi N, Hirata S, Iritani Y, et al. Clinical effects of long-term use of neutralised dialysate for continuous ambulatory peritoneal dialysis. Nephron 1992; 60:324-9.
5. Daugirdas JT, Chaurdry AH, Ing IL. Alkalinization of peritoneal dialysis solutions with sodium hydroxide or sodium bicarbonate. Artif Organs 1995; 12(3):203-5.
6. Henderson IS, Couper IA, Lumsden A. Potentially irritant glucose metabolites in unused CAPD fluid. In: Maher JF, Winchester JF, eds. Frontiers in peritoneal dialysis. New York: Field, Rich and Associates, Inc.; 1986: 261-4.
7. Simonsen O, Wieslander A, Landgren C, Rippe B. Less infusion pain and elevated level of cancer antigen 125 by the use of a new and more biocompatible PD fluid. In: Khanna R, ed. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Publications, 1996; 12:156-60.
8. Topley N, Coles GA, Williams JD. Biocompatibility studies on peritoneal cells. Perit Dial Int 1994; 14(3): S21-8.
9. Duwe AK, Vas SI, Weatherhead JW. Effects of the composition of peritoneal dialysis fluid on chemiluminescence, phagocytosis and bactericidal activity in vitro. Infect Immun 1981; 33:130-5.
10. Alscher DM, Magnus C, Kirchgessner J, Kuhlmann U, Mettang T. Influence of different peritoneal fluids on function of leukocytes [Abstract]. In: Nephrology 1999. Proceedings of the XVth International Congress of Nephrology; 2-6 May 1999; Buenos Aires, Argentina. Buenos Aires; 1999: 442.
11. Alobaidi HM, Coles GA, Davies M, Lloyd D. Host defence in continuous ambulatory peritoneal dialysis: The effect of the dialysate on phagocyte function. Nephrol Dial Transplant 1986; 1:16-21.
12. van Bronswijk H, Verbrugh HA, Heezius HC, van der Meulen J, Oe PL, Verhoef J. Dialysis fluids and local host resistance in patients on continuous ambulatory peritoneal dialysis. Eur J Clin Microbiol Infect Dis 1988; 7:368-73.
13. Irig BL, Gupta DK, Nawab ZM, Zhou FQ, Rahman MA, Daugirdas JT. Suppression of neutrophil superoxide production by conventional peritoneal dialysis solution. Int J Artif Organs 1988; 11:351-4.
14. Gordon DL, Rice JL, Avery VM. Surface phagocytosis and host defence in the peritoneal cavity during continuous ambulatory peritoneal dialysis. Eur J Clin Microbiol Infect Dis 1990; 9:191-7.
15. Yu AW, Zhou XJ, Zhou FQ, Nawab ZM, Gandhi VC, Ing TS, et al. Neutrophilic intracellular acidosis induced by conventional, lactate-containing peritoneal dialysis solutions. Int J Art Organs 1992; 15:661-5.
16. Liberek T, Topley N, Jörres A, Petersen MM, Coles GA, Gahl GM, et al. Peritoneal dialysis fluid inhibition of polymorphonuclear leukocyte respiratory burst activation is related to the lowering of intracellular pH. Nephron 1993; 65:260-5.
17. Douvdevani A, Rapoport J, Konforty A, Yulzari R, Moran A, Chaimovitz C. Intracellular acidification mediates the inhibitory effect of peritoneal dialysate on peritoneal macrophages. J Am Soc Nephrol 1995; 6(2):207-13.
18. Yamamoto T, Sakakura T, Yamakawa M, Horiuchi N, Hirata S, Iritani Y, et al. Clinical effects of long-term use of neutralized dialysate for continuous ambulatory peritoneal dialysis. Nephron 1992; 60:324-9.
19. Wieslander AP. Cytotoxicity of peritoneal dialysis fluid - Is it related to glucose breakdown products? Nephrol Dial Transplant 1996; 11:958-9.
20. Wieslander AP, Andren AHG, Nilsson-Thorell C, Muscalu N, Kjellstrand PTT, Rippe B. Are aldehydes in heat-sterilized peritoneal fluids toxic in vitro? Perit Dial Int 1995; 15:348-52.
21. Wieslander A, Linden T, Forsbäck G, Henle T, Deppisch R. 3-deoxyglucosone, a potential promotor of AGE, should be considered when developing new fluids for peritoneal dialysis [Abstract]. Perit Dial Int 1999; 19(Suppl 1):S86.
22. Jonasson P, Bagge U, Wieslander A, Braide M. Heat-sterilized PD fluid blocks leukocyte adhesion and increases flow velocity of rat peritoneal venules. Perit Dial Int 1996; 16(Suppl 1):S137-40.
23. Witowski J, Korybalska K, Wisniewska J, Breborowicz A, Gahl GM, Frei U, et al. Effect of glucose degradation products on human peritoneal mesothelial cell function. J Am Soc Nephrol 2000; 11:729-39.
24. Millar DJ, Dawnay ABS. Heat sterilization of PD fluid promotes advanced glycation end-product (AGE) formation [Abstract]. J Am Soc Nephrol 1995; 6:551.
25. Nakayama M, Kawaguchi Y, Yamada K, Hasegawa T, Takazoe K, Katoh N, et al. Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD. Kidney Int 1997; 51:182-6.
26. Honda K, Nitta K, Horita S, Yumura W, Nihei H, Nagai R, et al. Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration. Nephrol Dial Transplant 1999; 14:1541-9.
27. Tauer A, Schmitt R, Knerr T, Lage C, Passlick-Deetjen J, Pischetsrieder M. Formation of the glucose degradation product 3-deoxyglucosone and other carbonyl-compounds in single-or double-chamber peritoneal dialysis fluids [Abstract]. Perit Dial Int 2000; 20:142.
28. Jörres A, Witowski J, Mauder B, Gahl GM, Frei U, Passlick-Deetjen J. Mesothelial biocompatibility of Balance, a novel two-chambered, lactate-buffered peritoneal dialysis solution [Abstract]. In: Nephrology 1999. Proceedings of the XVth International Congress of Nephrology; 2-6 May 1999; Buenos Aires, Argentina. Buenos Aires; 1999: 441.
29. Bender TO, Witowski J, Passlick-Deetjen J, Gahl GM, Frei U, Jörres A. Reduced viability of human peritoneal mesothelial cells (HPMC) following "chronic" exposure to differently sterilized peritoneal fluids (PDF) [Abstract]. Perit Dial Int 2000; 20(Suppl 1):S9.
30. Feriani M. Bicarbonate-buffered CAPD solutions: From clinical trials to clinical practice. Perit Dial Int 1997; 17(Suppl 2):S51-5.
31. Feriani M, Ronco C, LaGreca G. Acid base balance with different CAPD solutions. Perit Dial Int 1996; 16(Suppl 1):S126-9.
32. Schmitt CP, Doetschmann R, Passlick-Deetjen J, Mehls O, Schaefer F. Comparison of acid-base and solute transport kinetics in children using bicarbonate-vs lactate-buffered PD fluids [Abstract]. Perit Dial Int 1999; 19(Suppl 1):S75.
33. Feriani M, Kirchgessner J, LaGreca G, Passlick-Deetjen J, and the Bicarbonate CAPD Cooperative Group. Randomized long-term evaluation of bicarbonate-buffered CAPD solution. Kidney Int 1998; 54:1731-8.
34. Feriani M, Biasioli S, Borin D, Bragantini L, Brendolan A, Chiaramonte S, et al. Bicarbonate buffer for CAPD solution. ASAIO Trans 1985; 31:668-72.
35. Jörres A, Gahl GM, Topley N, Neubauer A, Ludat K, Müller C, et al. In-vitro biocompatibility of alternative CAPD fluids; comparison of bicarbonate-buffered and glucose-polymer-based solutions. Nephrol Dial Transplant 1994; 9:785-90.
36. Jörres A, Bender TO, Finn A, Witowski J, Fröhlich S, Gahl GM, et al. Biocompatibility and buffers: Effect of bicarbonate-buffered peritoneal dialysis fluids on peritoneal cell function. Kidney Int 1998; 54:2184-93.